Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.100
+0.150 (7.69%)
At close: Aug 4, 2025, 4:00 PM
2.030
-0.070 (-3.33%)
Pre-market: Aug 5, 2025, 4:06 AM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $195.31 million as of August 4, 2025. Its market cap has decreased by -18.09% in one year.
Market Cap
195.31M
Enterprise Value
9.08M
1-Year Change
-18.09%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $195.31M, a decrease of -78.02%. That is a compound annual growth rate of -31.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 181.36M | 25.96% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |